Social and economic costs of attention-deficit/hyperactivity disorder across the lifespan

Emma Sciberras; Jared Streatfeild; Tristan Ceccato; Lynne Pezzullo; James G. Scott; Christel M. Middeldorp; Paul Hutchins; Roger Paterson; Mark A. Bellgrove; David Coghill

doi:10.1177/1087054720961828

Social and economic costs of attention-deficit/hyperactivity disorder across the lifespan

Emma Sciberras (Lead / Corresponding author), Jared Streatfeild, Tristan Ceccato, Lynne Pezzullo, James G. Scott, Christel M. Middeldorp, Paul Hutchins, Roger Paterson, Mark A. Bellgrove, David Coghill

Research output: Contribution to journal › Article › peer-review

40 Citations (Scopus)

Abstract

Objective: To determine the financial and non-financial costs of Attention-Deficit/Hyperactivity Disorder (ADHD) across the lifespan. Method: The population costs of ADHD in Australia were estimated for the financial year 2018 to 2019 using a prevalence approach to cost estimation across all ages. Financial (healthcare, productivity, education and justice systems, and deadweight losses) and non-financial costs were measured (Disability Adjusted Life Years (DALYs)). Results: The total social and economic cost of ADHD in 2018 to 2019 were US$12.76 billion (range US$8.40 billion to US$17.44 billion, with per person costs of US$15,664 per year). Productivity costs made up 81% of the total financial costs, followed by deadweight losses (11%), and health system costs (4%). Loss in terms of wellbeing was significant (US$5.31 billion). Conclusion: There is a need to raise public awareness of the considerable socioeconomic impact and burden of ADHD in order to drive investment and policy decisions that improve identification and treatment of ADHD.

Original language	English
Pages (from-to)	72-87
Number of pages	16
Journal	Journal of Attention Disorders
Volume	26
Issue number	1
Early online date	13 Oct 2020
DOIs	https://doi.org/10.1177/1087054720961828
Publication status	Published - Jan 2022

Keywords

ADHD
economic
costs
health care
education
justice
wellbeing

Access to Document

10.1177/1087054720961828

Cite this

@article{4e5fbbe31f3946e993cdd11570b5c8bb,

title = "Social and economic costs of attention-deficit/hyperactivity disorder across the lifespan",

abstract = "Objective: To determine the financial and non-financial costs of Attention-Deficit/Hyperactivity Disorder (ADHD) across the lifespan. Method: The population costs of ADHD in Australia were estimated for the financial year 2018 to 2019 using a prevalence approach to cost estimation across all ages. Financial (healthcare, productivity, education and justice systems, and deadweight losses) and non-financial costs were measured (Disability Adjusted Life Years (DALYs)). Results: The total social and economic cost of ADHD in 2018 to 2019 were US$12.76 billion (range US$8.40 billion to US$17.44 billion, with per person costs of US$15,664 per year). Productivity costs made up 81% of the total financial costs, followed by deadweight losses (11%), and health system costs (4%). Loss in terms of wellbeing was significant (US$5.31 billion). Conclusion: There is a need to raise public awareness of the considerable socioeconomic impact and burden of ADHD in order to drive investment and policy decisions that improve identification and treatment of ADHD.",

keywords = "ADHD, economic, costs, health care, education, justice, wellbeing",

author = "Emma Sciberras and Jared Streatfeild and Tristan Ceccato and Lynne Pezzullo and Scott, {James G.} and Middeldorp, {Christel M.} and Paul Hutchins and Roger Paterson and Bellgrove, {Mark A.} and David Coghill",

note = "The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was funded through the Australian Government under the Department of Health Mental Health program awarded to the Australian ADHD Professionals Association. ES is funded by a National Health and Medical Research Council Career Development Fellowship (NHMRC) (1110688) and a veski Inspiring Women{\textquoteright}s Fellowship. MAB is supported by a NHMRC Senior Research Fellowship (Level B) Funding sources did not have a role in analysis or interpretation of data.",

year = "2022",

month = jan,

doi = "10.1177/1087054720961828",

language = "English",

volume = "26",

pages = "72--87",

journal = "Journal of Attention Disorders",

issn = "1087-0547",

publisher = "SAGE Publications",

number = "1",

}

TY - JOUR

T1 - Social and economic costs of attention-deficit/hyperactivity disorder across the lifespan

AU - Sciberras, Emma

AU - Streatfeild, Jared

AU - Ceccato, Tristan

AU - Pezzullo, Lynne

AU - Scott, James G.

AU - Middeldorp, Christel M.

AU - Hutchins, Paul

AU - Paterson, Roger

AU - Bellgrove, Mark A.

AU - Coghill, David

N1 - The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was funded through the Australian Government under the Department of Health Mental Health program awarded to the Australian ADHD Professionals Association. ES is funded by a National Health and Medical Research Council Career Development Fellowship (NHMRC) (1110688) and a veski Inspiring Women’s Fellowship. MAB is supported by a NHMRC Senior Research Fellowship (Level B) Funding sources did not have a role in analysis or interpretation of data.

PY - 2022/1

Y1 - 2022/1

N2 - Objective: To determine the financial and non-financial costs of Attention-Deficit/Hyperactivity Disorder (ADHD) across the lifespan. Method: The population costs of ADHD in Australia were estimated for the financial year 2018 to 2019 using a prevalence approach to cost estimation across all ages. Financial (healthcare, productivity, education and justice systems, and deadweight losses) and non-financial costs were measured (Disability Adjusted Life Years (DALYs)). Results: The total social and economic cost of ADHD in 2018 to 2019 were US$12.76 billion (range US$8.40 billion to US$17.44 billion, with per person costs of US$15,664 per year). Productivity costs made up 81% of the total financial costs, followed by deadweight losses (11%), and health system costs (4%). Loss in terms of wellbeing was significant (US$5.31 billion). Conclusion: There is a need to raise public awareness of the considerable socioeconomic impact and burden of ADHD in order to drive investment and policy decisions that improve identification and treatment of ADHD.

AB - Objective: To determine the financial and non-financial costs of Attention-Deficit/Hyperactivity Disorder (ADHD) across the lifespan. Method: The population costs of ADHD in Australia were estimated for the financial year 2018 to 2019 using a prevalence approach to cost estimation across all ages. Financial (healthcare, productivity, education and justice systems, and deadweight losses) and non-financial costs were measured (Disability Adjusted Life Years (DALYs)). Results: The total social and economic cost of ADHD in 2018 to 2019 were US$12.76 billion (range US$8.40 billion to US$17.44 billion, with per person costs of US$15,664 per year). Productivity costs made up 81% of the total financial costs, followed by deadweight losses (11%), and health system costs (4%). Loss in terms of wellbeing was significant (US$5.31 billion). Conclusion: There is a need to raise public awareness of the considerable socioeconomic impact and burden of ADHD in order to drive investment and policy decisions that improve identification and treatment of ADHD.

KW - ADHD

KW - economic

KW - costs

KW - health care

KW - education

KW - justice

KW - wellbeing

U2 - 10.1177/1087054720961828

DO - 10.1177/1087054720961828

M3 - Article

C2 - 33047627

SN - 1087-0547

VL - 26

SP - 72

EP - 87

JO - Journal of Attention Disorders

JF - Journal of Attention Disorders

IS - 1

ER -

Social and economic costs of attention-deficit/hyperactivity disorder across the lifespan

Abstract

Keywords

Access to Document

Fingerprint

Cite this